Your browser doesn't support javascript.
loading
Correction to: The citrullinated/native index of autoantibodies against hnRNP-DL predicts an individual "window of treatment success" in RA patients.
Marklein, Bianka; Jenning, Madeleine; Konthur, Zoltán; Häupl, Thomas; Welzel, Franziska; Nonhoff, Ute; Krobitsch, Sylvia; Mulder, Debbie M; Koenders, Marije I; Joshua, Vijay; Cope, Andrew P; Shlomchik, Mark J; Anders, Hans-Joachim; Burmester, Gerd R; Hensvold, Aase; Catrina, Anca I; Rönnelid, Johan; Steiner, Günter; Skriner, Karl.
Afiliação
  • Marklein B; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Charite Campus Mitte, Rheumatologisches Forschungslabor - AG Skriner, Chariteplatz 1 (intern Virchowweg 11, 5.OG, R011), 10117, Berlin, Germany.
  • Jenning M; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Charite Campus Mitte, Rheumatologisches Forschungslabor - AG Skriner, Chariteplatz 1 (intern Virchowweg 11, 5.OG, R011), 10117, Berlin, Germany.
  • Konthur Z; German Rheumatism Research Centre, Leibniz Institute, 10117, Berlin, Germany.
  • Häupl T; Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Welzel F; Max Planck Institute of Colloids and Interfaces, Potsdam, Germany.
  • Nonhoff U; Department of Analytical Chemistry (Dpt.1), Bundesanstalt für Materialforschung und-prüfung (BAM), Berlin, Germany.
  • Krobitsch S; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Charite Campus Mitte, Rheumatologisches Forschungslabor - AG Skriner, Chariteplatz 1 (intern Virchowweg 11, 5.OG, R011), 10117, Berlin, Germany.
  • Mulder DM; Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Koenders MI; Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Joshua V; Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Cope AP; Department of Experimental Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Shlomchik MJ; Department of Experimental Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Anders HJ; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Burmester GR; Centre for Rheumatic Diseases, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Hensvold A; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Catrina AI; Medical Clinic and Policlinic IV, Nephrological Center, Ludwig-Maximilian-University Hospital, Munich, Germany.
  • Rönnelid J; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Charite Campus Mitte, Rheumatologisches Forschungslabor - AG Skriner, Chariteplatz 1 (intern Virchowweg 11, 5.OG, R011), 10117, Berlin, Germany.
  • Steiner G; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Skriner K; Academic Specialist Center, Center for Rheumatology, Stockholm Health Region, Stockholm, Sweden.
Arthritis Res Ther ; 23(1): 255, 2021 Oct 09.
Article em En | MEDLINE | ID: mdl-34627334
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article